Navigation Links
NeoGenomics to Present at the Noble Financial Equity Conference
Date:8/12/2008

FT. MYERS, Fla., Aug. 12 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) today announced that it will present at the Fourth Annual Noble Financial Equity Conference at 1:30 p.m. (Pacific) on Monday, August 18, 2008 at the Loews Lake Las Vegas Resort, Nevada.

Robert Gasparini, the Company's President and Chief Scientific Officer, and Steven Jones, the Company's Chief Financial Officer, will give a 23-minute presentation regarding NeoGenomics' market positioning, financial performance, and strategic direction. The presentation will be webcast LIVE featuring high-definition, streaming video and PowerPoint slides. Access is available by logging on to the conference website http://www.noblemadmax.com or directly via http://hosted.mediasite.com/hosted4/Viewer/?peid=d1e3b760-7d83-4d0a-86c1- 82908ba4ba0c. In addition, a portal to the webcast will be available in the Investor Relations section of the NeoGenomics' website. It is recommended that interested parties register at least 10 minutes prior to the start of the presentation to ensure timely access to the webcast.

About NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org .

Interested parties can also access additional investor relations material from the American Microcap Institute at http://www.americanmicrocapinstitute.com/ngnm/ or from Hawk Associates at http://www.hawkassociates.com. An investment profile about NeoGenomics may be found at http://www.hawkassociates.com/clients/additional/index.cfm?client_id=10.

About Noble Financial

Noble Financial is a privately-held, full-service capital markets firm driven by what is often overlooked by other firms -- uncovering the value embedded in the orphaned, undiscovered or misunderstood company. The company focuses on converting market inefficiencies into profit opportunities. Noble Financial supports emerging companies through strategic advice, investment banking, market-making, sales & trading, comprehensive equity research, and the development of institutional support. Noble Financial's equity conferences -- 2008 marks their fourth annual -- allow for a unique blend of professional and personal interaction among a diverse cross-section of executives. The company has operated for 24 years and has offices in Florida, New York City and Boston.


'/>"/>
SOURCE NeoGenomics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
2. NeoGenomics Announces Results for the 3rd Quarter 2007
3. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
4. Smart Balance to Webcast Presentation at Canaccord Adams Global Growth Conference
5. The Quantum Group to Present at the Noble Financial Equity Conference
6. Nautica Malibu Triathlon, Presented By Toyota, Showcases Athleticism, Philanthropy in 22nd Year
7. USA-ONE Interactive Presents a Free Webinar Series Introducing Docuvation – An Online Document Management Solution
8. AMA Foundation Presents $10,000 Scholarships to Promising Medical Students
9. STAAR Surgical to Present at the Noble Financial Equity Conference
10. Signs of Alzheimers disease may be present decades before diagnosis
11. Uroplasty to Present at the Noble Financial Fourth Annual Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , ... May 27, 2016 , ... With over 60 ... walk, the demand for a sustainable product to aid in the rehabilitation process has ... in the recovery of individuals with hemiplegia due to stroke. , Ekso Bionics has ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... caregivers to casual readers, this installment is bolstered by inspiring human-interest stories, courtesy ... trends and tech within the industry, from leading advocates, associations and industry leaders ...
(Date:5/27/2016)... ... 27, 2016 , ... Beleza Medspa has initiated a new program ... is the first time that Coolsculpting is being used for for more than just ... ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, 2016 , ... ... bolstered by inspiring human interest stories, which come courtesy of leaders in the nursing ... within the industry, from leading advocates and associations—namely Abilene Christian University. , As ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... name in the pharmaceutical, medical and food industries. Aside from its GMP accreditation, ... (SIC), providing proof of successfully certified products, services and staff. , Validation Center ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 Since ... matured into an essential life science tool for conducting ... applications. BCC Research reveals in its new report that ... growth phase, one powered by a range of new ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 ... bedient dringenden Bedarf zur ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur Entwicklung ... zu sein. Ein erstes Projekt wird die Entwicklung ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama ... $381 billion in 2015.  Though these are challenging ... of opportunity for success for companies that remain ... search of new growth prospects medical device companies ... research and development (R&D) than do companies in ...
Breaking Medicine Technology: